Advanced or recurrent endometrial carcinoma in adults who have disease progression on or following prior treatment with a platinum-containing therapy in any setting and are not candidates for curative surgery or radiation.

• Comparative Bioavailability of Lenvatinib 10 mg Capsules in Healthy Subjects Ended
  2022-501327-25-00 2 2023-05-13

Showing 1–1 of 1 trials